002737 葵花药业
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)-0.79610.76424.95821.91620.458
总资产报酬率 ROA (%)-0.6137.74416.08713.69313.113
投入资产回报率 ROIC (%)-0.75210.07021.73718.55717.909

边际利润分析
销售毛利率 (%)37.65344.89356.29157.74959.266
营业利润率 (%)0.14018.84023.97821.29719.844
息税前利润/营业总收入 (%)-0.60318.10423.20621.00219.830
净利润/营业总收入 (%)-2.72714.88720.43617.85717.090

收益指标分析
经营活动净收益/利润总额(%)1,017.57280.63488.88396.07590.943
价值变动净收益/利润总额(%)-397.1421.8832.257-0.9172.947
营业外收支净额/利润总额(%)137.680-0.277-0.890-0.3591.041

偿债能力分析
流动比率 (X)4.5263.7823.1502.2352.709
速动比率 (X)3.5892.9372.5761.9442.142
资产负债率 (%)17.40121.21427.27836.87630.169
带息债务/全部投入资本 (%)0.4981.924-0.50811.1460.508
股东权益/带息债务 (%)19,178.6934,866.788-18,419.112725.12217,605.289
股东权益/负债合计 (%)454.558354.335253.749162.156218.190
利息保障倍数 (X)2.589-26.468-41.386-95.903-89.227

营运能力分析
应收账款周转天数 (天)34.14314.6096.89412.25013.031
存货周转天数 (天)198.352168.347108.747112.202125.985